Nova Patents
PL366307A1

Humanized anti-lt-beta-r antibodies

Abstract

Humanized antibodies to LT- beta -R and method of use thereof are provided.

Term

Term ended

Projected expiry passed 12 October 2021, 5 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

99 members in 30 offices

This recordMember, by publication datePriority claim20 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
24028500United States of AmericaP
24028500United States of AmericaP
27528901United States of AmericaP
27528901United States of AmericaP
29998701United States of AmericaP
29998701United States of AmericaP
0060240285–––
0160275289–––
0160299987–––
US20000240285P–––
US20010275289P–––
US20010299987P–––

Members99

Family members, oldest first
DocumentOfficeKind
CA2425809A1CanadaA1
WO0230700A2World Intellectual Property Organization (WIPO)A2
WO0230986A2World Intellectual Property Organization (WIPO)A2
AU1174702AAustraliaA
AU1321002AAustraliaA
WO0233529A2World Intellectual Property Organization (WIPO)A2
WO0233673A2World Intellectual Property Organization (WIPO)A2
AU1320902AAustraliaA
AU2437402AAustraliaA
WO0234571A2World Intellectual Property Organization (WIPO)A2
AU2437302AAustraliaA
WO0239761A2World Intellectual Property Organization (WIPO)A2
AU3765002AAustraliaA
US2002091473A1United States of AmericaA1
WO0239761A3World Intellectual Property Organization (WIPO)A3
WO0233529A3World Intellectual Property Organization (WIPO)A3
WO0233673A3World Intellectual Property Organization (WIPO)A3
WO0234571A3World Intellectual Property Organization (WIPO)A3
US2002116156A1United States of AmericaA1
US2002120371A1United States of AmericaA1
US2002120374A1United States of AmericaA1
WO0230700A3World Intellectual Property Organization (WIPO)A3
US2002151297A1United States of AmericaA1
WO0230700A8World Intellectual Property Organization (WIPO)A8
WO0230986A3World Intellectual Property Organization (WIPO)A3
NO20031642D0NorwayD0
IS6779AIcelandA
KR20030041164ARepublic of KoreaA
NO20031642LNorwayL
US6580973B2United States of AmericaB2
KR20030055282ARepublic of KoreaA
KR20030059193ARepublic of KoreaA
EP1326759A2European Patent Office (EPO)A2
EP1326897A2European Patent Office (EPO)A2
EP1328421A2European Patent Office (EPO)A2
EP1328857A2European Patent Office (EPO)A2
EP1329116A2European Patent Office (EPO)A2
EP1330377A2European Patent Office (EPO)A2
KR20030064765ARepublic of KoreaA
EE200300179AEstoniaA
KR20030070888ARepublic of KoreaA
KR20030070889ARepublic of KoreaA
SK5672003A3SlovakiaA3
CZ20031307A3CzechiaA3
HU0302573A2HungaryA2
EA200300464A1Eurasian Patent Organization (EAPO)A1
IL155340D0IsraelD0
BG107802ABulgariaA
US2004058394A1United States of AmericaA1
JP2004512609AJapanA
AR035352A1ArgentinaA1
JP2004515848AJapanA
JP2004518461AJapanA
JP2004524203AJapanA
TR200300478T2TürkiyeT2
JP2004532608AJapanA
JP2004533732AJapanA
CN1547590AChinaA
ZA200303347BSouth AfricaB
MXPA03003144AMexicoA
PL366307A1This recordPolandA1
US6909947B2United States of AmericaB2
US6925425B2United States of AmericaB2
EP1328857B1European Patent Office (EPO)B1
EP1328421B1European Patent Office (EPO)B1
AT312377TAustriaT
AT313127TAustriaT
DE60115693D1GermanyD1
DE60115940D1GermanyD1
BR0114646ABrazilA
GEP20063752BGeorgiaB
DK1328421T3DenmarkT3
YU28503AYugoslavia, later Serbia and Montenegro (until 2006)A
ES2254526T3SpainT3
EA006945B1Eurasian Patent Organization (EAPO)B1
DE60115940T2GermanyT2
ES2256319T3SpainT3
DE60115693T2GermanyT2
EP1326759B1European Patent Office (EPO)B1
AT346764TAustriaT
DE60124937D1GermanyD1
TR200602095T2TürkiyeT2
ES2275748T3SpainT3
DE60124937T2GermanyT2
AU2002211747B2AustraliaB2
EP1326759B8European Patent Office (EPO)B8
NZ525793ANew ZealandA
KR100860952B1Republic of KoreaB1
US7429644B2United States of AmericaB2
JP2008282022AJapanA
KR100872000B1Republic of KoreaB1
US2009092601A1United States of AmericaA1
US7565230B2United States of AmericaB2
JP4307833B2JapanB2
KR100943397B1Republic of KoreaB1
EP1330377B1European Patent Office (EPO)B1
AT500996TAustriaT
DE60144191D1GermanyD1
EP1330377B8European Patent Office (EPO)B8